Tandem Capital Management Corp Astrazeneca PLC Transaction History

Tandem Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $238,535 - $275,357	-5,058 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$48.52 - $58.02 $23,871 - $28,545	492 Added 10.78%	5,058 $253,000
Q1 2020 May 12, 2020	SELL	$37.79 - $51.33 $24,941 - $33,877	-660 Reduced 12.63%	4,566 $204,000
Q4 2019 Mar 04, 2020	BUY	$42.46 - $50.46 $221,895 - $263,703	5,226 New	5,226 $261,000

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

Stay updated on Tandem Capital Management Corp with notifications on news.